<DOC>
	<DOCNO>NCT02504723</DOCNO>
	<brief_summary>Gastric variceal obturation current endoscopic therapy choice gastric variceal bleeding associate high rebleeding rate . Carvedilol potent non-selective β-blocker . The role carvedilol prevention recurrent gastric variceal bleed study . This study aim evaluate efficacy carvedilol adjunct gastric variceal obturation secondary prophylaxis gastric variceal bleeding .</brief_summary>
	<brief_title>Carvedilol Adjunct Endoscopic Cyanoacrylate Injection Secondary Prophylaxis Gastric Variceal Bleeding</brief_title>
	<detailed_description>Gastric variceal bleed lethal complication portal hypertension . The rebleeding rate range 30 % 50 % patient initial hemostasis . Endoscopic cyanoacrylate injection currently choice endoscopic therapy acute gastric variceal bleed prevention recurrent bleeding . However , rebleeding rate still high patient undergo repeat endoscopic cyanoacrylate injection . Non-selective β-blockers frequently use secondary prophylaxis variceal bleeding . In case esophageal varix , combination non-selective β-blockers endoscopic therapy significantly lower rebleeding rate compare endoscopic therapy alone . However , propranolol fail decrease rebleeding rate adjunct endoscopic cyanoacrylate injection associate high incidence adverse effect gastric variceal bleeding patient . A potent non-selective β-blocker propranolol might decrease portal pressure decrease rebleeding rate . Carvedilol potent non-selective β-blocker beta alpha-1 blocker effect . It significantly lower portal pressure even propranolol non-responders . However , unclear weather carvedilol play role prevention recurrent gastric variceal bleeding . The investigator conduct randomize control trial compare efficacy carvedilol combine endoscopic cyanoacrylate injection endoscopic cyanoacrylate injection alone secondary prophylaxis gastric variceal bleeding .</detailed_description>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Age 20 80 year Cirrhotic patient acute gastric variceal bleed proven endoscopy within 24 h bleed Stable hemodynamic condition least 3 day cyanoacrylate injection Previous treatment gastric varix , include endoscopic therapy , transjugular intrahepatic portosystemic shunt , surgery Contraindications nonselective betablockers cyanoacrylate injection Serum total bilirubin &gt; 10 mg/dL Grade III/IV hepatic encephalopathy Hepatorenal syndrome Severe heart failure ( NYHA Fc III/IV ) Chronic kidney disease renal replacement therapy Refractory ascites Malignancy hepatocellular carcinoma Pregnancy Pacemaker use Refusal participate</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Gastric varix</keyword>
	<keyword>cyanoacrylate</keyword>
	<keyword>carvedilol</keyword>
</DOC>